Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
…, Y Nakamura, N Enomoto, K Ide, M Toyoshima… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…
[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease
…, N Inui, K Yokomura, N Koshimizu, M Toyoshima… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
Interstitial lung diseases associated with amyopathic dermatomyositis
…, D Hashimoto, J Sato, M Toyoshima… - European …, 2006 - Eur Respiratory Soc
The aim of the present study was to clarify the clinical characteristics and prognosis of
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…
Alterations in smoking habits are associated with acute eosinophilic pneumonia
…, M Shirai, H Gemma, T Shirai, M Toyoshima… - Chest, 2008 - Elsevier
Background Acute eosinophilic pneumonia (AEP) is characterized by a febrile illness, diffuse
pulmonary infiltrates, and pulmonary eosinophilia. The etiology of AEP remains unknown, …
pulmonary infiltrates, and pulmonary eosinophilia. The etiology of AEP remains unknown, …
Bronchiolar disease in rheumatoid arthritis.
…, A Sato, S Imokawa, M Toyoshima… - American journal of …, 1996 - atsjournals.org
The pulmonary manifestations of rheumatoid arthritis (RA) include bronchiolar diseases
such as follicular bronchiolitis (FB) and bronchiolitis obliterans (BO). In this study, we …
such as follicular bronchiolitis (FB) and bronchiolitis obliterans (BO). In this study, we …
A clinical study of idiopathic eosinophilic pneumonia
H Hayakawa, A Sato, M Toyoshima, S Imokawa… - Chest, 1994 - Elsevier
To better characterize idiopathic eosinophilic pneumonia (IEP), we studied the clinical and
laboratory features of 27 patients. Patients with IEP could be divided into those with chronic …
laboratory features of 27 patients. Patients with IEP could be divided into those with chronic …
Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease. A Preliminary Study
S Miwa, M Shirai, M Toyoshima, T Shirai… - Annals of the …, 2014 - atsjournals.org
Rationale: Patients with Mycobacterium avium complex pulmonary disease are frequently
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …
[HTML][HTML] Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study
…, K Yokomura, N Koshimizu, M Toyoshima… - Respiratory …, 2017 - Elsevier
Background Although the accurate diagnosis of pleuroparenchymal fibroelastosis (PPFE)
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …
[HTML][HTML] Assessment of immune-related interstitial lung disease in patients with NSCLC treated with immune checkpoint inhibitors: a multicenter prospective study
…, M Kato, H Matsuda, S Matsuura, M Toyoshima… - Journal of Thoracic …, 2020 - Elsevier
Introduction Programmed cell death protein 1 immune checkpoint inhibitors (ICIs) have
been reported to improve the survival of patients with NSCLC. On the expansion of clinical …
been reported to improve the survival of patients with NSCLC. On the expansion of clinical …
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial
…, K Yokomura, N Koshimizu, M Toyoshima… - …, 2021 - Wiley Online Library
Background and objective The efficacy of combination therapy with corticosteroids and CNI,
TAC and CsA, for PM/DM‐ILD has been described retrospectively. However, it remains …
TAC and CsA, for PM/DM‐ILD has been described retrospectively. However, it remains …